Author

P. Atri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A.-K. Hadjantonakis· 1 shared D. Doss· 1 shared D. G. Macalinao· 1 shared D. Klinkebiel· 1 shared D. Pe'er· 1 shared E. Brogi· 1 shared E. Seffar· 1 shared G. A. Talmon· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A.-K. Hadjantonakis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Distinct tumor architectures for metastatic colonization of the brain

S. Gan, D. G. Macalinao, S. H. Shahoei, L. Tian, X. Jin, H. Basnet, J. T. Muller, P. Atri, E. Seffar, W. Chatila, A.-K. Hadjantonakis, N. Schultz, E. Brogi, T. A. Bale, D. Pe'er, J. Massague

This study compares the brain metastasis colonization strategies of triple-negative breast cancer and HER2+ breast cancer, revealing distinct tumor architectures and stromal interactions.

bioRxiv · Jan 27, 2023 · PreprintCancer Biology

MiR-212-3p functions as a tumor suppressor gene in group 3 medulloblastoma via targeting Nuclear Factor I/B (NFIB)

N. Perumal, R. Kanchan, D. Doss, N. Bastola, P. Atri, R. Chirravuri Venkata, I. Thapa, D. Klinkebiel, G. A. Talmon, M. W. Nasser, S. K. Batra, S. Mahapatra

This study identifies miR-212-3p as a tumor suppressor in group 3 medulloblastoma by targeting NFIB, reducing cancer cell proliferation and metastasis.

bioRxiv · Apr 15, 2021Cancer Biology